PO.CL07.03 · 临床研究
Targeting DNA Repair, Cell Cycle, and Tumor Metabolism
-
-
- 1258 1258 Harnessing combinatorial nanomedicine for simultaneous BRD4 degradation and stromal disruption against pancreatic ductal adenocarcinoma Drishti Rathod, Ketankumar Patel
- 1260 1260 LIPA inhibition enhances the therapeutic efficacy of DNA-damaging agents in ovarian cancer through induction of ER stress and enhancing DNA damage Durga Meenakshi Panneerdoss, Tae-Kyung Lee, Khaled Mohamed Nassar, Gaurav Sharma, Scott Terry Elmore, Henry Neal, William Cole Arnold, Edward Kost, Suryavathi Viswanadhapalli, Jung-Mo Ahn, Ganesh V. Raj, Ratna K. Vadlamudi
-
-
-
- 1264 1264 Limited apoptotic response in RBM10 wild type/deficient EGFR-mutant lung cancer patient-derived models overcome by combined EGFR and BCL-2/BCL-xL inhibition Jonathan Wesley Riess, Hongyong Zhang, Jasmine Diaz Sezati, Peyton Apruzzese, Dongguang Wei, Tiffany Le, Luis G. Carvajal-Carmona
-
-
-
-
-
-
-
-
- 1276 1276 Dual epigenetic-kinase targeting to overcome resistance and immune evasion in hepatocellular carcinoma Kyounghyun Kim, HongDuck Yun, Gabin Kwon
- 1277 1277 Overcoming glioblastoma resistance by targeting its heterogeneity with a synergistic approach: TTFields stimulation and tmCLIC1 impairment Francesca Cianci, Elisa Meraviglia, Guido Rey, Stefania Castiglione, Antonio M. Polito, Sara Torabi, CHIARA MERCURIO, Dietmar Krex, Tatiana Vorobyov, Kerem Wainer-Katsir, Martin Gabay, YAARA PORAT, Roni Blatt, Ori Braten, Tullio Florio, Itai Tzchori, Michele Mazzanti
-
-
